Form 8-K TERADYNE, INC For: Jul 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Form 8-K TERADYNE, INC For: Jul 24
July 29, 2024 6:59 AM EDT
Baird analyst Richard Eastman raised the price target on Teradyne (NASDAQ: TER) to $140.00 (from $120.00) while maintaining a Outperform rating.
The analyst comments "Remain Outperform. 2Q beat, but 3Q guided just below Cons.. Negative stock reaction (TER -13%, SP500 -0.5%) followed as... More
July 26, 2024 12:54 PM EDT
Citi analyst Atif Malik lowered the price target on Teradyne (NASDAQ: TER) to $162.00 (from $185.00) while maintaining a Buy rating.
The analyst comments "We update our model post Jun-Q results and lower our CY24/25/26 EPS estimates 1%/3%/3% on revised SOC TAM assumptions (see Figure 1). Fundamentally,... More
July 26, 2024 6:52 AM EDT
Northland analyst Gus Richard lowered the price target on Teradyne (NASDAQ: TER) to $126.00 (from $136.00) while maintaining a Market Perform rating.
The analyst comments "TER guidance was disappointing, as the upside of Semitest was offset by weakness in IA and System Test.... More
July 26, 2024 6:50 AM EDT
Cantor Fitzgerald analyst C.J. Muse lowered the price target on Teradyne (NASDAQ: TER) to $160.00 (from $180.00) while maintaining a Neutral rating.
The analyst comments "Teradyne posted a solid beat followed by a modest miss, resulting in combined 2Q/3Q rev/EPS tracking to $1.44B/$1.62 vs. cons of $1.41B/$1.62 coming in. For a stock that rallied ~50% over the last 3 months, this was clearly not good enough.... More
July 26, 2024 5:53 AM EDT
Goldman Sachs analyst Toshiya Hari lowered the price target on Teradyne (NASDAQ: TER) to $151.00 (from $161.00) while maintaining a Conviction Buy rating.
The analyst comments "Although Teradynes 3Q24 outlook fell short of elevated expectations and we are reducing near-term estimates to... More
July 25, 2024 1:51 PM EDT
Stifel analyst Brian Chin lowered the price target on Teradyne (NASDAQ: TER) to $140.00 (from $150.00) while maintaining a Hold rating.
The analyst comments "Teradynes expectations didnt change (much), but the markets (including ours) had. We did expect a slightly better update on... More
